PDPK1 抗体
PDPK1
适用: 人, 小鼠
WB, IHC, IF/ICC
宿主: 兔
Polyclonal
unconjugated
-
-
抗原
See all PDPK1 抗体
-
PDPK1
(3-phosphoinositide Dependent Protein Kinase-1 (PDPK1))
-
适用
-
人, 小鼠
-
宿主
-
兔
-
克隆类型
-
多克隆
-
标记
-
This PDPK1 antibody is un-conjugated
-
应用范围
-
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (fixed cells) (IF/ICC)
-
纯化方法
-
Affinity purified
-
免疫原
-
Recombinant protein of human PDPK1.
-
亚型
-
IgG
-
Top Product
-
Discover our top product PDPK1 Primary Antibody
-
-
-
应用备注
-
Optimal working dilution should be determined by the investigator.
-
限制
-
仅限研究用
-
-
状态
-
Liquid
-
浓度
-
Lot specific
-
缓冲液
-
PBS, pH 7.3, 0.02 % sodium azide, 50 % glycerol.
-
储存液
-
Sodium azide
-
注意事项
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
-
-20 °C
-
储存方法
-
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
-
抗原
-
PDPK1
(3-phosphoinositide Dependent Protein Kinase-1 (PDPK1))
-
别名
-
PDPK1 (PDPK1 产品)
-
别名
-
pdpk1 antibody, MGC82080 antibody, PDK1 antibody, PDPK2 antibody, PRO0461 antibody, Pdk1 antibody, zgc:153787 antibody, 3'-phosphoinositide-dependent protein kinase 1 antibody, 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1 antibody, ATPDK1 antibody, AtPDK1 antibody, T32M21.110 antibody, T32M21_110 antibody, zgc:77318 antibody, 3-phosphoinositide dependent protein kinase 1 antibody, 3-phosphoinositide dependent protein kinase 1 L homeolog antibody, 3-phosphoinositide dependent protein kinase-1 antibody, 3-phosphoinositide dependent protein kinase 1a antibody, 3-phosphoinositide-dependent protein kinase 1 antibody, 3'-phosphoinositide-dependent protein kinase 1 antibody, 3-phosphoinositide dependent protein kinase 1b antibody, PDPK1 antibody, pdpk1.L antibody, pdpk1 antibody, Pdpk1 antibody, pdpk1a antibody, LOC100380750 antibody, pdk-1 antibody, PDK1 antibody, pdpk1b antibody
-
分子量
-
Calculated MW: 48 kDa/50 kDa/58 kDa/60 kDa/63 kDa
Observed MW: 65 kDa
-
基因ID
-
5170
-
UniProt
-
O15530
-
途径
-
PI3K-Akt Signaling, TCR Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Regulation of Cell Size, Skeletal Muscle Fiber Development, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
-